Novel analysis method has potential in diagnostics – technology is being tested in cancer management
Press release, 20 June 2022 The VerSiLiB project coordinated by VTT aims at a completely new method for analysing liquid biopsy samples and tests its suitability for cancer management. The aim is to simultaneously measure both protein and DNA biomarkers in blood with single-molecule sensitivity, which is not possible with current methods. The basic principles of the new method have been verified previously, so the present aim is to develop technology and demonstrate its functionality with clinical samples.The project ‘Versatile Amplification Method for Single-Molecule Detection in Liquid